The Unexpected Skin Effects of GLP-1 Drugs: A Systematic Review
GLP-1 receptor agonists show direct dermatological effects including potential benefits for inflammatory skin diseases, expanding their therapeutic profile beyond metabolism.
Quick Facts
What This Study Found
GLP-1 RAs exert direct dermatological effects including potential benefits in inflammatory skin diseases, expanding their known therapeutic profile beyond metabolic applications.
Key Numbers
51 studies met criteria. 34 reported adverse effects (hypersensitivity, injection-site reactions, pruritus, urticaria, angioedema, bullous pemphigoid). 17 reported beneficial outcomes (psoriasis, HS, wound healing).
How They Did This
Systematic review of EMBASE, PubMed, Web of Science, and Google Scholar from 2014-2025, including peer-reviewed human studies on GLP-1 RA dermatological effects.
Why This Research Matters
With millions of people now taking GLP-1 drugs, understanding skin effects helps clinicians and patients anticipate dermatological changes and could open new treatment paths for skin diseases.
The Bigger Picture
GLP-1 receptors throughout the body continue to reveal new therapeutic possibilities. Dermatological effects add yet another dimension to these increasingly versatile medications.
What This Study Doesn't Tell Us
Heterogeneous studies with varying designs. Some skin effects may be related to weight loss rather than direct GLP-1 receptor activity in skin.
Questions This Raises
- ?Which inflammatory skin diseases respond best to GLP-1 RA treatment?
- ?Are skin effects dose-dependent or specific to certain GLP-1 drugs?
Trust & Context
- Key Stat:
- 2014-2025 evidence reviewed Decade of literature shows GLP-1 drugs have direct effects on skin beyond their metabolic benefits
- Evidence Grade:
- Systematic review of mostly observational studies and case reports. While methodologically sound, the underlying evidence is heterogeneous.
- Study Age:
- Published in 2025, providing the most comprehensive review of GLP-1 RA dermatological effects to date.
- Original Title:
- A Closer Look at the Dermatological Profile of GLP-1 Agonists.
- Published In:
- Diseases (Basel, Switzerland), 13(5) (2025)
- Authors:
- Persson, Calista, Eaton, Allison, Mayrovitz, Harvey N
- Database ID:
- RPEP-13029
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Can GLP-1 drugs affect your skin?
Yes. This review found both beneficial effects (particularly for inflammatory skin conditions) and some adverse skin reactions. GLP-1 receptors are present in skin cells, meaning these drugs can directly influence skin biology.
Could GLP-1 drugs help treat skin diseases like psoriasis?
Emerging evidence suggests possible benefits for inflammatory skin diseases. Some studies report improvements in psoriasis and other conditions. However, more research is needed before GLP-1 drugs could be recommended specifically for skin diseases.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13029APA
Persson, Calista; Eaton, Allison; Mayrovitz, Harvey N. (2025). A Closer Look at the Dermatological Profile of GLP-1 Agonists.. Diseases (Basel, Switzerland), 13(5). https://doi.org/10.3390/diseases13050127
MLA
Persson, Calista, et al. "A Closer Look at the Dermatological Profile of GLP-1 Agonists.." Diseases (Basel, 2025. https://doi.org/10.3390/diseases13050127
RethinkPeptides
RethinkPeptides Research Database. "A Closer Look at the Dermatological Profile of GLP-1 Agonist..." RPEP-13029. Retrieved from https://rethinkpeptides.com/research/persson-2025-a-closer-look-at
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.